findmyKOL
Clinical trialNCT05094635UnknownObservational

Immunogenicity Against SARS-CoV-2 in COVID-19 Close Contacts

SponsorUniversity of Medicine and Pharmacy at Ho Chi Minh CityEnrollment772Covid19Vaccine Reaction
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Vietnam
  • University of Medicine and Pharmacy

    Ho Chi Minh City, Vietnam

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2021
Primary completion
31 Dec 2021
Completion
1 May 2022
Last update posted
1 Nov 2021
Registered enrollment
772
Registry id
NCT05094635

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.